Redirecting carbon flux into malonyl-CoA to improve resveratrol titers: Proof of concept for genetic interventions predicted by OptForce computational framework

Abstract Malonyl-CoA is the limiting precursor for the overexpression of an array of heterologous pathways in bacteria, such as flavanones, polyketides, microdiesel and poly-unsaturated omega-3 fatty acids. Previously, we have been able to develop a strain with higher carbon flux to acetyl-coA and malonyl-CoA by carrying out genetic interventions predicted by OptForce framework. Here we carried out the same interventions in a resveratrol producing strain and obtained a 60% increase in the yield giving the highest titer of 1.6 g/L obtained in lab scale fermentation without the addition of expensive fatty acid pathway inhibitors such as cerulenin. The positive genetic alterations involved overexpression of pyruvate dehydrogenase multi-enzyme complex (PDH), phosphoglycerate kinase (PGK), glyceraldehyde-3-phosphate dehydrogenase (GapA) and deletion of fumarase (FumC). This work presents the development of an alternative source of resveratrol with possible applications in pharmaceutical, nutraceutical and food industry.

[1]  Tomer Shlomi,et al.  Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways , 2010, Bioinform..

[2]  J. Wood,et al.  Sirtuin activators mimic caloric restriction and delay ageing in metazoans , 2004, Nature.

[3]  C. Pan,et al.  Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model. , 2005, Transplantation proceedings.

[4]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[5]  Zachary L. Fowler,et al.  Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA. , 2011, Metabolic engineering.

[6]  A. Burgard,et al.  Exploring the overproduction of amino acids using the bilevel optimization framework OptKnock , 2003, Biotechnology and bioengineering.

[7]  Jinhua Dong,et al.  Synthesis and anti-inflammatory activity of resveratrol analogs. , 2005, Chemical & pharmaceutical bulletin.

[8]  Huimin Zhao,et al.  Improving cellular malonyl-CoA level in Escherichia coli via metabolic engineering. , 2009, Metabolic engineering.

[9]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[10]  Y Takamura,et al.  Changes in the intracellular concentration of acetyl-CoA and malonyl-CoA in relation to the carbon and energy metabolism of Escherichia coli K12. , 1988, Journal of general microbiology.

[11]  Zachary L. Fowler,et al.  Increased Malonyl Coenzyme A Biosynthesis by Tuning the Escherichia coli Metabolic Network and Its Application to Flavanone Production , 2009, Applied and Environmental Microbiology.

[12]  C. Maranas,et al.  An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. , 2006, Metabolic engineering.

[13]  C. Rock,et al.  Regulation of fatty acid biosynthesis in Escherichia coli. , 1993, Microbiological reviews.

[14]  N. Ahmad,et al.  Prevention of Ultraviolet-B Radiation Damage by Resveratrol in Mouse Skin Is Mediated via Modulation in Survivin¶ , 2005, Photochemistry and photobiology.

[15]  V. Adhami,et al.  Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. , 2003, Toxicology and applied pharmacology.

[16]  A. Bhardwaj,et al.  Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. , 2004, Journal of nutritional science and vitaminology.

[17]  Costas D Maranas,et al.  Microbial 1-butanol production: Identification of non-native production routes and in silico engineering interventions. , 2010, Biotechnology journal.

[18]  D. Adu,et al.  Alcohol and red wine: impact on cardiovascular risk , 2004 .

[19]  C. Pan,et al.  Resveratrol prolongs allograft survival after liver transplantation in rats. , 2005, World journal of gastroenterology.

[20]  Steffen Schaffer,et al.  Considerable Increase in Resveratrol Production by Recombinant Industrial Yeast Strains with Use of Rich Medium , 2010, Applied and Environmental Microbiology.

[21]  A. Burgard,et al.  Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization , 2003, Biotechnology and bioengineering.

[22]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[24]  M. Belvisi,et al.  Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF‐κB‐independent mechanism , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Zachary L. Fowler,et al.  High-Yield Resveratrol Production in Engineered Escherichia coli , 2011, Applied and Environmental Microbiology.

[26]  Peng Xu,et al.  ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli. , 2012, ACS synthetic biology.

[27]  Jennifer L. Reed,et al.  OptORF: Optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains , 2010, BMC Systems Biology.

[28]  R. Mahadevan,et al.  The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.

[29]  Costas D. Maranas,et al.  OptForce: An Optimization Procedure for Identifying All Genetic Manipulations Leading to Targeted Overproductions , 2010, PLoS Comput. Biol..